A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : LPA / lymphocyte proliferation assay

[Related PubMed/MEDLINE]
Total Number of Papers: 56
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   LPA  (>> Co-occurring Abbreviation)
Long Form:   lymphocyte proliferation assay
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 Anti-inflammatory profile of Aegle marmelos (L) Correa (Bilva) with special reference to young roots grown in different parts of India. 5-LOX, COX-1, COX-2
2018 Polymorphisms in HLA-C and KIR alleles are not associated with HAM/TSP risk in HTLV-1-infected subjects. IIER, PVL
2017 Supplementation of vitamin E, selenium and increased energy allowance mitigates the transition stress and improves postpartum reproductive performance in the crossbred cow. CAT, CON, MDA, NEBAL, PA, SOD, TAC
2016 Genome-Wide Association Study of Cell-Mediated Response in Dogs Naturally Infected by Leishmania infantum. CanL, CMI, GWAS, IFN-gamma, IL-10, LST, SNPs, TGF-beta, TNF-alpha
2016 Invitro rapid diagnostic tests for severe drug hypersensitivity reactions in children. DHR, IFN-gamma, IL-4
2015 Extracellular vesicles secreted by bone marrow- and adipose tissue-derived mesenchymal stromal cells fail to suppress lymphocyte proliferation. LP, MSC-EVs
2015 Further Stimulation of Cellular Immune Responses through Association of HPV-16 E6, E7 and L1 Genes in order to produce more Effective Therapeutic DNA Vaccines in Cervical Cancer Model. HPV
2014 HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNalpha2a and Ribavirin: a randomized controlled trial. HCV, NOB, SVR
2014 Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: a randomized study. ELISPOT, HBV, IFN, YU
10  2013 High prevalence of skin disorders among HTLV-1 infected individuals independent of clinical status. HAM/TSP, HTLV-1, IDH, SD
11  2013 In vitro diagnostic assays are effective during the acute phase of delayed-type drug hypersensitivity reactions. DHR, IFN, IL
12  2012 A novel assay for detection of hepatitis C virus-specific effector CD4(+) T cells via co-expression of CD25 and CD134. HCV, ICC
13  2012 Lymphocyte proliferation specific for recall, CMV and HIV antigens in miniaturized and automated format. ---
14  2012 Phase I safety and immunogenicity evaluations of an alphavirus replicon HIV-1 subtype C gag vaccine in healthy HIV-1-uninfected adults. CTL, ELISA, ICS, VEE
15  2011 Reduced immunogenicity of influenza vaccines in HIV-infected compared with uninfected pregnant women is associated with regulatory T cells. ELISPOT, GMTs, HAI
16  2010 A whole blood lymphocyte proliferation assay in healthy Thais: comparison of heparinized blood and acid citrate dextrose blood. ACD, PBMC, PHA, PWM, SI
17  2010 Comparison of immunologic assays for detecting immune responses in HIV immunotherapeutic studies: AIDS Clinical Trials Group Trial A5181. ART, B-LCLs, CP, ELISPOT, ICC, IL-2, PBMCs
18  2010 Evaluation of humoral and antigen-specific T-cell responses after vaccination of pigs against pseudorabies in the presence of maternal antibodies. CMI, MDA, PBMC, PRV
19  2010 Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania. ELISA, IFN-gamma, LAM, MV, TB
20  2010 Interferon gamma responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis. Ag85, BCG, CI, HIV, WCL
21  2010 Mycobacterium vaccae vaccine to prevent tuberculosis in high risk people: a meta-analysis. CCTs, CV, MV, MVS, PI, RCTs, RD, RR, SI, TB
22  2010 Treatment of experimental autoimmune uveoretinitis with intravitreal injection of tacrolimus (FK506) encapsulated in liposomes. DTH, EAU, ERG
23  2009 Inhibition of MAP kinases and down regulation of TNF-alpha, IL-beta and COX-2 genes by the crude extracts from marine bacteria. COX-2, IL-1beta, MAP, PBMCs, TNF-alpha
24  2009 Lymphocyte proliferation to mycobacterial antigens is detectable across a spectrum of HIV-associated tuberculosis. Ag85, BCG, ESAT-6, IFN-gamma, TST, WCL
25  2009 Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization. PBMC
26  2009 Relationship of reconstituted adaptive and innate cytomegalovirus (CMV)-specific immune responses with CMV viremia in hematopoietic stem cell transplant recipients. CMV, ELISPOT
27  2009 Suppression of experimental autoimmune uveoretinitis by Anti-IL-17 antibody. DTH, EAU, ELISA, IFN, IRBP
28  2008 Development of a storage-compatible microtiter plate-based technique for lymphocyte proliferation. ---
29  2008 In vitro cell-mediated immune responses of human immunodeficiency virus-infected and -uninfected individuals to whole cytomegalovirus antigens and their subunits. CMI, CMV, HIV, IL-2
30  2007 Cellular and humoral immune responses to a tetanus toxoid booster in perinatally HIV-1-infected children and adolescents receiving highly active antiretroviral therapy (HAART). CR, HAART, HIV-1, TT
31  2007 Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans. ADCC, CRA
32  2007 Leishmania-specific isotype levels and their relationship with specific cell-mediated immunity parameters in canine leishmaniasis. CMI, IFN, LST
33  2007 Lessons from a multisite international trial in the Caribbean and South America of an HIV-1 Canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120. CTL, ELISA, ELISPOT, IFN-gamma, NIAID
34  2006 Immune response to Leishmania infantum in healthy horses in Spain. ---
35  2006 Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge. i.n, IFU, MOMP, MoPn
36  2005 Analogues of cyclolinopeptide A containing alpha-hydroxymethyl amino acid residues. CLA, HmL, HmV
37  2005 Comparison of three assays for the evaluation of specific cellular immunity to Leishmania infantum in dogs. IFNB, LST
38  2005 Conjunctival vaccination of the brushtail possum (Trichosurus vulpecula) with bacille Calmette-Guerin. BCG, CFU, PPD, PV
39  2005 Oral vaccination of brushtail possums (Tichosurus vulpecula) with BCG: immune responses, persistence of BCG in lymphoid organs and excretion in faeces. BCG, CFU, GALT, MLN, PP, PPD, PV
40  2004 Excess apoptosis of mononuclear cells contributes to the depressed cytomegalovirus-specific immunity in HIV-infected patients on HAART. CMI, CMV, HAART, uPBMC
41  2003 Immunogenicity of an inactivated mycobacterial vaccine for the prevention of HIV-associated tuberculosis: a randomized, controlled trial. BCG, CV, IFN-gamma, MV
42  2002 Vaccination of donkeys against Babesia equi using killed merozoite immunogen. ELISA, Hb, PC, SI, TLC
43  2002 Vaccination of the brushtail possum (Trichosurus vulpecula) against Mycobacterium bovis infection with bacille Calmette-Guerin: the response to multiple doses. ---
44  2001 Immunization with HIV-1 subtype B gp160-DNA induces specific as well as cross reactive immune responses in mice. CTL, env
45  2001 Skin test reactivity and cellular immune responses to Mycobacterium avium sensitin in AIDS patients at risk for disseminated M. avium infection. ---
46  2001 Vaccination with a CDR2 BV6S2/6S5 peptide in adjuvant induces peptide-specific T-cell responses in patients with multiple sclerosis. DTH, IFA, MS
47  2000 Effect of cryopreservation on measurement of cytomegalovirus-specific cellular immune responses in HIV-infected patients. CMI, CMV, IFN-gamma, IL-2, PBMCs, RCF
48  2000 Patterns of CD8 T cell clonal dominance in response to change in antiretroviral therapy in HIV-infected children. ART, PCR, TCR
49  2000 Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials Group. DTH, HepA, KLH, TT
50  1999 Delayed-type hypersensitivity to recombinant HIV envelope glycoprotein (rgp160) after immunization with homologous antigen. CI, DTH
51  1998 Effect of shipment, storage, anticoagulant, and cell separation on lymphocyte proliferation assays for human immunodeficiency virus-infected patients. ACD, CPT, HIV, PBMC
52  1996 Development of mucosal and systemic lymphoproliferative responses and protective immunity to human group A rotaviruses in a gnotobiotic pig model. MNC
53  1994 Serial study of the immune response of an individual with exacerbated simple cutaneous leishmaniasis. MEA
54  1989 Lymphoproliferative response to fusion proteins of human papillomaviruses in patients with cervical intraepithelial neoplasia. CIN, CMI, HPV-16
55  1988 Humoral and cellular immunity to papillomavirus in patients with cervical dysplasia. CIN, E.I, ELISA, HPV, SI
56  1976 Specific antigen stimulated lymphocyte proliferation in osteosarcoma. PBL